AHMEDABAD, India, Oct. 12, 2021 Intas Pharmaceuticals, has made a progressive breakthrough in the Antifungal Therapy domain with the launch of the world's first Super Bioavailable Itraconazole-SB 100mg by the Brand Name of Itaspor-SB Forte/Subawin. It has been recently approved by Indian Regulatory Authorities. Conventional Itraconazole mainstay drug to fight fungal infection…
BEDFORD, Mass. USA October 11, 2021 Eastern Daylight Time Ocular Therapeutix, Inc. (NASDAQ:OCUL) , a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced the U.S. Food and Drug Administration (FDA) has approved its Supplemental New Drug Application (sNDA)…
MUMBAI, India, Oct. 11, 2021 Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company today announced the launch of a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name Tavulus® in Spain, for the treatment of chronic obstructive pulmonary disease (COPD). In November 2017, a Glenmark European…
ALBA TEAM's PAP is the best certification. Patient Assistance Programs abbreviated as "PAP". We don't do business certification for members. We think the best certification is to help the ultimate beneficiaries. Therefore, joining ALBA TEAM, initiating PAPs, and initiating or participating in at least 2 "PAPs" every year is the…
The following is the list of ALBA TEAM members participating in ALBA Lighting PAP ，Through them, assistance response can be obtained . Contact Language Type Lien-Teh ALL （By using translation software） ALBA-S 100PEI Healthcare 简体中文&繁体中文（First language） ALBA-D Click the member name to view the contact information When applying for assistance, the…
ALBA Lighting：Covid-19 infection Patient Assistance Programs abbreviated as "ALBA Lighting PAP". Project objectives The ALBA Lighting PAP aims to help coronavirus infected patients who lack medical resources during the COVID-19 pandemic. Project application conditions The applicant must satisfied the following basic conditions, medical conditions and economic conditions at the same…
September 1, 2021 Today，Lianteh is open to registered members of suppliers. Welcome to the free advertising service provided by LienTeh． To learn how to become a member, go to "Become a supplier". Because we are still in the COVID-19 pandemic, we will try our best to help patients with lack…
संकलन उद्देश्य विश्वव्यापी कोरोनाभाइरस （कोविड १）） महामारी को समयमा, हामीले अविकसित देशहरु र क्षेत्रहरु मा साधारण मानिसहरुलाई नर्सि nursing ज्ञान प्रदान गर्नु पर्छ चिकित्सा स्रोतहरु को उपयोग को लागी क्रम मा जीवित रहने दर सुधार गर्न को लागी। यो गाइड एक अस्थायी गाइड हो। यदि तपाइँ चिकित्सा संगठनहरु बाट सहयोग…
គោលបំណងចងក្រង ក្នុងកំឡុងពេលមានជំងឺរាតត្បាតសកលកូវីដ -១៩ រាតត្បាតយើងគួរតែផ្តល់ចំណេះដឹងផ្នែកគិលានុបដ្ឋយិកាដល់ប្រជាជនសាមញ្ញនៅក្នុងប្រទេសនិងតំបន់ដែលកំពុងអភិវឌ្withoutន៍ដោយមិនមានលទ្ធភាពទទួលបានប្រភពវេជ្ជសាស្ត្រដើម្បីធ្វើឱ្យអត្រារស់រានមានជីវិតប្រសើរឡើង។ មគ្គុទេសក៍នេះគឺជាការណែនាំបណ្តោះអាសន្ន។ សូមកុំសំដៅលើវាប្រសិនបើអ្នកអាចទទួលជំនួយពីអង្គការវេជ្ជសាស្ត្រ។ ពាក្យគន្លឹះCovid-19，ការថែទាំខ្លួនឯងនៅក្នុងតំបន់ដែលគ្មានលក្ខខណ្ឌសុខភាព គោលបំណង：About LienTeh រក្សាសិទ្ធិ：CC BY-NC-SA 4.0 ជ្រើសរើសអ្នកស្ម័គ្រចិត្ត 1. បកប្រែ មគ្គុទ្ទេសក៍នេះត្រូវការបកប្រែជាភាសាផ្សេងៗ។ ឯកសារនេះត្រូវបានបកប្រែដោយម៉ាស៊ីន។ 2. កំពុងកែសំរួល សង្ឃឹមថាអ្នកជំនាញជាច្រើននឹងចង្អុលបង្ហាញពីភាពមិនសមហេតុផលនៅក្នុងការណែនាំនេះនិងបន្ថែមគ្រោងការណ៍ដែលអាចប្រតិបត្តិបាន។ 3. ទាក់ទងមកពួកយើង អត្ថបទនេះត្រូវបានបកប្រែដោយម៉ាស៊ីនហើយមិនត្រូវបានផ្ទៀងផ្ទាត់ទេ។ ប្រសិនបើមានកំហុសណាមួយសូមទាក់ទងមកយើងខ្ញុំ។ Email：care@lienteh.net ការធ្វើរោគវិនិច្ឆ័យ៖ តើធ្វើដូចម្តេចដើម្បីវិនិច្ឆ័យការឆ្លងមេរោគ? ការធ្វើរោគវិនិច្ឆ័យភាពយឺតយ៉ាវ (មុនពេលចាប់ផ្តើម) ការពិនិត្យអេកូឡូស៊ី៖ តេស្តអាស៊ីតនុយក្លេអ៊ែរកូរ៉ូណាវ៉ាវីថ្មី (វិជ្ជមាន?) ការពិនិត្យរោគសាស្ត្រ៖ តេស្តអង្គបដិបក្ខ IgM ជាក់លាក់ថ្មីរបស់កូរ៉ូណាវ៉ាវី (វិជ្ជមាន?) ការធ្វើរោគវិនិច្ឆ័យក្រោយការចាប់ផ្តើម ការពិនិត្យអេកូឡូស៊ី៖ តេស្តអាស៊ីតនុយក្លេអ៊ែរកូរ៉ូណាវ៉ាវីថ្មី (វិជ្ជមាន?) ការពិនិត្យរោគសាស្ត្រ៖ តេស្តអង្គបដិបក្ខ IgM ជាក់លាក់ថ្មីរបស់កូរ៉ូណាវ៉ាវី (វិជ្ជមាន?) ការពិនិត្យមើលទ្រូង៖ ភាពផ្ទុយគ្នានៃរោគសាស្ត្រ (ថាតើការរួមបញ្ចូលគ្នានៃសួតការហូរឈាមតាមរន្ធគូថការពង្រីកស្រមោលបេះដូងនិងការហើមសួត?) ចំពោះតំបន់ដែលមិនមានលក្ខខណ្ឌបច្ចេកទេសវាពឹងផ្អែកជាចម្បងលើលក្ខណៈដូចខាងក្រោមដើម្បីកំណត់ថាតើកូវីដ…
စုစည်းမှုရည်ရွယ်ချက် ကမ္ဘာလုံးဆိုင်ရာကိုရိုနာဗိုင်းရပ်စ် (Covid-19) ကပ်ရောဂါကာလအတွင်းကျွန်ုပ်တို့သည်ရှင်သန်မှုနှုန်းကိုမြှင့်တင်နိုင်ရန်ဖွံ့ဖြိုးမှုနောက်ကျသောနိုင်ငံများနှင့်ဒေသများရှိသာမန်လူများအားသူနာပြုအသိပညာပေးသင့်သည်။ ဤလမ်းညွှန်သည်ယာယီလမ်းညွှန်ဖြစ်သည်။ ဆေးဘက်ဆိုင်ရာအဖွဲ့အစည်းများ၏အကူအညီကိုရနိုင်လျှင် ကျေးဇူးပြု၍ ၎င်းကိုမရည်ညွှန်းပါနှင့်။ သော့ချက်စာလုံးများ：Covid-19, ကျန်းမာရေးအခြေအနေမရှိသောဒေသများတွင်မိမိကိုယ်ကိုစောင့်ရှောက်မှုပေးခြင်း ရည်ရွယ်ချက်：About LienTeh မူပိုင်ခွင့်：CC BY-NC-SA 4.0 စေတနာ့ဝန်ထမ်းခေါ်ယူပါ 1.၁ ။ ဘာသာပြန်ပါ ဤလမ်းညွှန်ကိုဘာသာစကားအမျိုးမျိုးသို့ဘာသာပြန်ရန်လိုသည်။ ဤမှတ်တမ်းကိုစက်ဖြင့်ဘာသာပြန်ထားသည်။ 2.၂ ။ ပြန်လည်စစ်ဆေးခြင်း ဒီလမ်းညွှန်ချက်မှာအသုံးမ ၀ င်တဲ့ပညာရှင်တွေကိုထောက်ပြပြီးပိုပြီးအကောင်ထည်ဖော်နိုင်တဲ့အစီအမံတွေထပ်ထည့်လိမ့်မယ်လို့မျှော်လင့်ပါတယ်။ 3.၃ ။ ကြှနျုပျတို့ကိုဆကျသှယျရနျ ဤဆောင်းပါးကိုစက်ဖြင့်ဘာသာပြန်ထားပြီးအတည်မပြုရသေးပါ။ အမှားအယွင်းများရှိပါက ကျေးဇူးပြု၍ ကျွန်ုပ်တို့ကိုဆက်သွယ်ပါ။ Email：care@lienteh.net ရောဂါရှာဖွေခြင်း - ကူးစက်မှုကိုမည်သို့ဆုံးဖြတ်ရမည်နည်း။ အောင်းနေချိန်ရောဂါရှာဖွေခြင်း (ကြိုတင်စတင်ခြင်း) Etiological စစ်ဆေးခြင်း: Coronavirus nucleic acid စမ်းသပ်မှုအသစ် (အပြုသဘောလား။ ) Serological စစ်ဆေးခြင်း:…
LUCIUS Pharmaceutical anuncia la aprobación de LuciAcor en L…Компания LUCIUS Pharmaceutical объявляет об одобрении препар…
LienTeh Network Announces New Content Strategy Focused on Lo…
LienTeh Network anuncia una nueva estrategia de contenido ce…LUCIUS Pharmaceutical announces the approval LuciAcor in Lao…
Copyright © 2021-2022 LienTeh.net All rights reserved.
